163 related articles for article (PubMed ID: 24935471)
1. ADAM10 regulates proliferation, invasion, and chemoresistance of bladder cancer cells.
Fu L; Liu N; Han Y; Xie C; Li Q; Wang E
Tumour Biol; 2014 Sep; 35(9):9263-8. PubMed ID: 24935471
[TBL] [Abstract][Full Text] [Related]
2. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
Yuan S; Lei S; Wu S
Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
[TBL] [Abstract][Full Text] [Related]
3. Effects of ADAM10 upregulation on progression, migration, and prognosis of nasopharyngeal carcinoma.
You B; Shan Y; Shi S; Li X; You Y
Cancer Sci; 2015 Nov; 106(11):1506-14. PubMed ID: 26310711
[TBL] [Abstract][Full Text] [Related]
4. ADAM10 is upregulated in melanoma metastasis compared with primary melanoma.
Lee SB; Schramme A; Doberstein K; Dummer R; Abdel-Bakky MS; Keller S; Altevogt P; Oh ST; Reichrath J; Oxmann D; Pfeilschifter J; Mihic-Probst D; Gutwein P
J Invest Dermatol; 2010 Mar; 130(3):763-73. PubMed ID: 19865098
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells.
Yue Y; Shao Y; Luo Q; Shi L; Wang Z
Biomed Res Int; 2013; 2013():434561. PubMed ID: 23936798
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ADAM10 inhibits migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis.
Li D; Xiao Z; Wang G; Song X
Mol Med Rep; 2015 Oct; 12(4):5517-23. PubMed ID: 26135838
[TBL] [Abstract][Full Text] [Related]
7. ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer.
Feldinger K; Generali D; Kramer-Marek G; Gijsen M; Ng TB; Wong JH; Strina C; Cappelletti M; Andreis D; Li JL; Bridges E; Turley H; Leek R; Roxanis I; Capala J; Murphy G; Harris AL; Kong A
Oncotarget; 2014 Aug; 5(16):6633-46. PubMed ID: 24952873
[TBL] [Abstract][Full Text] [Related]
8. Expression of A disintegrin and metalloprotease 10 in pancreatic carcinoma.
Gaida MM; Haag N; Günther F; Tschaharganeh DF; Schirmacher P; Friess H; Giese NA; Schmidt J; Wente MN
Int J Mol Med; 2010 Aug; 26(2):281-8. PubMed ID: 20596609
[TBL] [Abstract][Full Text] [Related]
9. Silencing ADAM10 inhibits the in vitro and in vivo growth of hepatocellular carcinoma cancer cells.
Liu S; Zhang W; Liu K; Ji B; Wang G
Mol Med Rep; 2015 Jan; 11(1):597-602. PubMed ID: 25323956
[TBL] [Abstract][Full Text] [Related]
10. ADAM10 overexpression confers resistance to doxorubicin-induced apoptosis in hepatocellular carcinoma.
Yang CL; Jiang FQ; Xu F; Jiang GX
Tumour Biol; 2012 Oct; 33(5):1535-41. PubMed ID: 22581584
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.
Liu S; Zhang W; Liu K; Wang Y; Ji B; Liu Y
Oncol Rep; 2014 Dec; 32(6):2501-10. PubMed ID: 25242535
[TBL] [Abstract][Full Text] [Related]
12. miR-365 inhibits cell invasion and migration of triple negative breast cancer through ADAM10.
Liu F; Zhuang L; Wu R; Li D
J BUON; 2019; 24(5):1905-1912. PubMed ID: 31786854
[TBL] [Abstract][Full Text] [Related]
13. Knockout of ADAM10 enhances sorafenib antitumor activity of hepatocellular carcinoma in vitro and in vivo.
Zhang W; Liu S; Liu K; Ji B; Wang Y; Liu Y
Oncol Rep; 2014 Nov; 32(5):1913-22. PubMed ID: 25176394
[TBL] [Abstract][Full Text] [Related]
14. Effect of A disintegrin and metalloproteinase 10 gene silencing on the proliferation, invasion and migration of the human tongue squamous cell carcinoma cell line TCA8113.
Shao Y; Sha XY; Bai YX; Quan F; Wu SL
Mol Med Rep; 2015 Jan; 11(1):212-8. PubMed ID: 25333745
[TBL] [Abstract][Full Text] [Related]
15. miR-320a modulates cell growth and chemosensitivity via regulating ADAM10 in gastric cancer.
Ge X; Cui H; Zhou Y; Yin D; Feng Y; Xin Q; Xu X; Liu W; Liu S; Zhang Q
Mol Med Rep; 2017 Dec; 16(6):9664-9670. PubMed ID: 29152656
[TBL] [Abstract][Full Text] [Related]
16. ADAM10 is required for SCF-induced mast cell migration.
Faber TW; Pullen NA; Fernando JF; Kolawole EM; McLeod JJ; Taruselli M; Williams KL; Rivera KO; Barnstein BO; Conrad DH; Ryan JJ
Cell Immunol; 2014 Jul; 290(1):80-8. PubMed ID: 24950026
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal effects between microRNA-140-5p and ADAM10 suppress migration and invasion of human tongue cancer cells.
Kai Y; Peng W; Ling W; Jiebing H; Zhuan B
Biochem Biophys Res Commun; 2014 Jun; 448(3):308-14. PubMed ID: 24530397
[TBL] [Abstract][Full Text] [Related]
18. The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.
Haining EJ; Yang J; Bailey RL; Khan K; Collier R; Tsai S; Watson SP; Frampton J; Garcia P; Tomlinson MG
J Biol Chem; 2012 Nov; 287(47):39753-65. PubMed ID: 23035126
[TBL] [Abstract][Full Text] [Related]
19. MicroR-140-5p suppresses tumor cell migration and invasion by targeting ADAM10-mediated Notch1 signaling pathway in hypopharyngeal squamous cell carcinoma.
Jing P; Sa N; Liu X; Liu X; Xu W
Exp Mol Pathol; 2016 Feb; 100(1):132-8. PubMed ID: 26704053
[TBL] [Abstract][Full Text] [Related]
20. Expression and biological roles of SATB1 in human bladder cancer.
Han B; Luan L; Xu Z; Wu B
Tumour Biol; 2013 Oct; 34(5):2943-9. PubMed ID: 23696028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
